Triptorelin market value is predicted to reach USD 1.49 billion by 2032, according to a new research report by Global Market Insights Inc. Rising awareness about precocious puberty is a key driver ...
Review the side-effects of Triptorelin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Elderly patients with metastatic castrate-resistant prostate cancer (mCRPC): Safety and efficacy of docetaxel retreatment. Background: Medical castration using gonadotropin-releasing hormone (GnRH) ...
Please provide your email address to receive an email when new articles are posted on . Women with polycystic ovary syndrome have less increase in follicle-stimulating hormone after triptorelin ...
March 15, 2010 — The US Food and Drug Administration (FDA) has approved a twice-yearly 22.5-mg formulation of triptorelin pamoate injection (Trelstar, Watson Pharmaceuticals, Inc) for the palliative ...
Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with ...
Nodal Stage Classification for Breast Carcinoma: Improving Interobserver Reproducibility Through Standardized Histologic Criteria and Image-Based Training Prospectively collected hormonal data were ...
You might have triptorelin for early breast cancer with other hormone treatments if you have not gone through the menopause ( pre menopausal ). Men can also have triptorelin for breast cancer. The ...
Lausanne, Switzerland - January 13, 2016 - Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced a collaboration in order ...
Details concerning the Triptorelin Pamoate for Injectable Suspension medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...
The global triptorelin market is set for substantial growth, according to the latest market analysis report. Forecasts indicate that the market, valued at approximately USD 955.50 million in 2023, is ...
The Triptorelin Market is expected to be worth around US$ 955.50 million in 2023. Industry is predicted to expand at a 5% CAGR from 2023 to 2033, powered by the rising prevalence of endometriosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results